XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Paid-in Capital
Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interest
Beginning balance at Dec. 31, 2021 $ 5,085,556 $ (161,420) $ 2,827 $ 7,557,297 $ (307,640) $ 302,276 $ 146,220 $ (710,885) $ (2,065,959) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Activity related to employee stock plans 17,928   3 17,888   37        
Changes related to cash flow derivative hedges 195,901             195,901    
Change in defined benefit plans 12,597             12,597    
Foreign currency translation adjustments 7,778             7,778    
Purchase of treasury stock (2,270)               (2,270)  
Net Loss (1,167,142)         (1,167,142)        
Ending balance at Mar. 31, 2022 3,988,928   2,830 7,267,545   (718,609)   (494,609) (2,068,229) 0
Beginning balance at Dec. 31, 2022 2,868,812   2,832 7,284,852   (1,707,429)   (643,214) (2,068,229) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Activity related to employee stock plans 21,351   8 21,343            
Changes related to cash flow derivative hedges (31,697)             (31,697)    
Change in defined benefit plans 3,513             3,513    
Foreign currency translation adjustments (6,546)             (6,546)    
Purchase of treasury stock (1,203)               (1,203)  
Noncontrolling Interest 219,101     45,298           173,803
Net Loss (47,910)         (47,910)        
Ending balance at Mar. 31, 2023 $ 3,025,421   $ 2,840 $ 7,351,493   $ (1,755,339)   $ (677,944) $ (2,069,432) $ 173,803